Login

Company overview with CEO | Phil Hartstein , President & CEO at FINJAN HOLDINGS, INC. 00:10:00

Share On Facebook Share On Twitter

Phil Hartstein is a President & CEO at FINJAN HOLDINGS, INC.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Allergy Therapeutics to sniff out more M&A deals - Manuel Llobert, CEO, Allergy Therapeutics
00:10:00
Aspire Mining: Mongolian Coking Coal Developer with Significant Projects
00:10:00
Invest Barbados - Investor Tales from Barbados - Jo Edghill | Tyrone Browne, , Barbados (TS)
00:10:00
Angshu Mallick Reviews Adani Wilmar's IPO Journey and Market Potential | Angshu Mallick, CEO , Adani Wilmar Ltd.
00:10:00
Interview with Wayne Taylor, CEO of Heron Resources, at One-to-One Mining Conference
00:10:00
Phalangeal Exploration Inc: Exploring Gold Opportunities in Canada and West Africa
00:10:00
BBVA's Successful Year: Growth, Profitability, and Societal Impact | Carlos Torres Vila , President , BBVA .
00:10:00
Bunker Hill Mine: Revitalizing an Iconic U.S. Silver and Base Metal Asset
00:10:00
Expecting "plenty of news flow" from the JAC zone, AbraSilver Resource Corp. | John Miniotis, CEO, AbraSilver Resource CorpABRA:CVE
00:10:00
Toni Townes-Whitley, CEO of Science Applications International Corp. (SAIC), discusses the company's AI investments and fourth-quarter performance.
00:10:00
Reducing Audit Costs: Insights from Erez Bahar | EREZ BAHAR, Managing Partner at Davidson & Company LLP
00:10:00
Lance Knaack: My Path to Financial Planning | Lance Knaack, Associate Financial Planner of Syverson Strege

© 2017 - Neuhu+